2024-01-012024-12-312024-12-31false11097500DENTAL IMPLANT SOLUTIONS LIMITED2025-01-29falseiso4217:GBPxbrli:pure110975002024-01-01110975002024-12-31110975002024-01-012024-12-31110975002023-01-01110975002023-12-31110975002023-01-012023-12-3111097500bus:SmallEntities2024-01-012024-12-3111097500bus:AuditExempt-NoAccountantsReport2024-01-012024-12-3111097500bus:FullAccounts2024-01-012024-12-3111097500bus:PrivateLimitedCompanyLtd2024-01-012024-12-3111097500core:WithinOneYear2024-12-3111097500core:AfterOneYear2024-12-3111097500core:WithinOneYear2023-12-3111097500core:AfterOneYear2023-12-3111097500core:ShareCapital2024-12-3111097500core:SharePremium2024-12-3111097500core:RevaluationReserve2024-12-3111097500core:OtherReservesSubtotal2024-12-3111097500core:RetainedEarningsAccumulatedLosses2024-12-3111097500core:ShareCapital2023-12-3111097500core:SharePremium2023-12-3111097500core:RevaluationReserve2023-12-3111097500core:OtherReservesSubtotal2023-12-3111097500core:RetainedEarningsAccumulatedLosses2023-12-3111097500core:LandBuildings2024-12-3111097500core:PlantMachinery2024-12-3111097500core:Vehicles2024-12-3111097500core:FurnitureFittings2024-12-3111097500core:OfficeEquipment2024-12-3111097500core:NetGoodwill2024-12-3111097500core:IntangibleAssetsOtherThanGoodwill2024-12-3111097500core:ListedExchangeTraded2024-12-3111097500core:UnlistedNon-exchangeTraded2024-12-3111097500core:LandBuildings2023-12-3111097500core:PlantMachinery2023-12-3111097500core:Vehicles2023-12-3111097500core:FurnitureFittings2023-12-3111097500core:OfficeEquipment2023-12-3111097500core:NetGoodwill2023-12-3111097500core:IntangibleAssetsOtherThanGoodwill2023-12-3111097500core:ListedExchangeTraded2023-12-3111097500core:UnlistedNon-exchangeTraded2023-12-3111097500core:LandBuildings2024-01-012024-12-3111097500core:PlantMachinery2024-01-012024-12-3111097500core:Vehicles2024-01-012024-12-3111097500core:FurnitureFittings2024-01-012024-12-3111097500core:OfficeEquipment2024-01-012024-12-3111097500core:NetGoodwill2024-01-012024-12-3111097500core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3111097500core:ListedExchangeTraded2024-01-012024-12-3111097500core:UnlistedNon-exchangeTraded2024-01-012024-12-3111097500core:MoreThanFiveYears2024-01-012024-12-3111097500core:Non-currentFinancialInstruments2024-12-3111097500core:Non-currentFinancialInstruments2023-12-3111097500dpl:CostSales2024-01-012024-12-3111097500dpl:DistributionCosts2024-01-012024-12-3111097500core:LandBuildings2024-01-012024-12-3111097500core:PlantMachinery2024-01-012024-12-3111097500core:Vehicles2024-01-012024-12-3111097500core:FurnitureFittings2024-01-012024-12-3111097500core:OfficeEquipment2024-01-012024-12-3111097500dpl:AdministrativeExpenses2024-01-012024-12-3111097500core:NetGoodwill2024-01-012024-12-3111097500core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3111097500dpl:GroupUndertakings2024-01-012024-12-3111097500dpl:ParticipatingInterests2024-01-012024-12-3111097500dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3111097500core:ListedExchangeTraded2024-01-012024-12-3111097500dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3111097500core:UnlistedNon-exchangeTraded2024-01-012024-12-3111097500dpl:CostSales2023-01-012023-12-3111097500dpl:DistributionCosts2023-01-012023-12-3111097500core:LandBuildings2023-01-012023-12-3111097500core:PlantMachinery2023-01-012023-12-3111097500core:Vehicles2023-01-012023-12-3111097500core:FurnitureFittings2023-01-012023-12-3111097500core:OfficeEquipment2023-01-012023-12-3111097500dpl:AdministrativeExpenses2023-01-012023-12-3111097500core:NetGoodwill2023-01-012023-12-3111097500core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3111097500dpl:GroupUndertakings2023-01-012023-12-3111097500dpl:ParticipatingInterests2023-01-012023-12-3111097500dpl:GroupUndertakingscore:ListedExchangeTraded2023-01-012023-12-3111097500core:ListedExchangeTraded2023-01-012023-12-3111097500dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-01-012023-12-3111097500core:UnlistedNon-exchangeTraded2023-01-012023-12-3111097500core:NetGoodwill2024-12-3111097500core:IntangibleAssetsOtherThanGoodwill2024-12-3111097500core:LandBuildings2024-12-3111097500core:PlantMachinery2024-12-3111097500core:Vehicles2024-12-3111097500core:FurnitureFittings2024-12-3111097500core:OfficeEquipment2024-12-3111097500core:AfterOneYear2024-12-3111097500core:WithinOneYear2024-12-3111097500core:ListedExchangeTraded2024-12-3111097500core:UnlistedNon-exchangeTraded2024-12-3111097500core:ShareCapital2024-12-3111097500core:SharePremium2024-12-3111097500core:RevaluationReserve2024-12-3111097500core:OtherReservesSubtotal2024-12-3111097500core:RetainedEarningsAccumulatedLosses2024-12-3111097500core:NetGoodwill2023-12-3111097500core:IntangibleAssetsOtherThanGoodwill2023-12-3111097500core:LandBuildings2023-12-3111097500core:PlantMachinery2023-12-3111097500core:Vehicles2023-12-3111097500core:FurnitureFittings2023-12-3111097500core:OfficeEquipment2023-12-3111097500core:AfterOneYear2023-12-3111097500core:WithinOneYear2023-12-3111097500core:ListedExchangeTraded2023-12-3111097500core:UnlistedNon-exchangeTraded2023-12-3111097500core:ShareCapital2023-12-3111097500core:SharePremium2023-12-3111097500core:RevaluationReserve2023-12-3111097500core:OtherReservesSubtotal2023-12-3111097500core:RetainedEarningsAccumulatedLosses2023-12-3111097500core:NetGoodwill2023-01-0111097500core:IntangibleAssetsOtherThanGoodwill2023-01-0111097500core:LandBuildings2023-01-0111097500core:PlantMachinery2023-01-0111097500core:Vehicles2023-01-0111097500core:FurnitureFittings2023-01-0111097500core:OfficeEquipment2023-01-0111097500core:AfterOneYear2023-01-0111097500core:WithinOneYear2023-01-0111097500core:ListedExchangeTraded2023-01-0111097500core:UnlistedNon-exchangeTraded2023-01-0111097500core:ShareCapital2023-01-0111097500core:SharePremium2023-01-0111097500core:RevaluationReserve2023-01-0111097500core:OtherReservesSubtotal2023-01-0111097500core:RetainedEarningsAccumulatedLosses2023-01-0111097500core:AfterOneYear2024-01-012024-12-3111097500core:WithinOneYear2024-01-012024-12-3111097500core:Non-currentFinancialInstrumentscore:CostValuation2024-01-012024-12-3111097500core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-012024-12-3111097500core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-012024-12-3111097500core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-012024-12-3111097500core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-012024-12-3111097500core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-012024-12-3111097500core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3111097500core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3111097500core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3111097500core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3111097500core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3111097500core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3111097500core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3111097500core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3111097500core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3111097500core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3111097500core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3111097500core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3111097500core:Non-currentFinancialInstrumentscore:CostValuation2023-12-3111097500core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-3111097500core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-3111097500core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-3111097500core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-3111097500core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-3111097500core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-3111097500core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-3111097500core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-3111097500bus:Director12024-01-012024-12-31

DENTAL IMPLANT SOLUTIONS LIMITED

Registered Number
11097500
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2024

DENTAL IMPLANT SOLUTIONS LIMITED
Company Information
for the year from 1 January 2024 to 31 December 2024

Director

NESBITT, Andrew Thomas

Registered Address

The Orangery Rangemore Gardens
Rangemore
Burton On Trent
DE13 9RG

Registered Number

11097500 (England and Wales)
DENTAL IMPLANT SOLUTIONS LIMITED
Statement of Financial Position
31 December 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Intangible assets3240,000240,000
240,000240,000
Current assets
Debtors1,1341,144
Cash at bank and on hand70,47872,943
71,61274,087
Creditors amounts falling due within one year4(321,612)(313,102)
Net current assets (liabilities)(250,000)(239,015)
Total assets less current liabilities(10,000)985
Net assets(10,000)985
Capital and reserves
Called up share capital100100
Profit and loss account(10,100)885
Shareholders' funds(10,000)985
The financial statements were approved and authorised for issue by the Director on 29 January 2025, and are signed on its behalf by:
NESBITT, Andrew Thomas
Director
Registered Company No. 11097500
DENTAL IMPLANT SOLUTIONS LIMITED
Notes to the Financial Statements
for the year ended 31 December 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 Section 1A, The Financial Reporting Standard applicable in the UK and Republic of Ireland.
Going concern
The UK economy has recently been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company's trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a going concern basis.
Revenue from sale of goods
The revenue shown in the profit and loss account represents income receivable from dental treatments carried out during the period. Revenue in respect of dental treatment uncompleted at the year end date is recognised by reference to the state of completion.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Goodwill
Goodwill arising on an acquisition of a business is carried at cost less accumulated impairment losses, if any. Goodwill is amortised over its expected useful life which is estimated to be ten years. Goodwill is assessed for impairment when there are indicators of impairment and any impairment is charged to the income statement. No reversals of impairment are recognised.
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
2.Average number of employees

20242023
Average number of employees during the year00
3.Intangible assets

Goodwill

Total

££
Cost or valuation
At 01 January 24240,000240,000
At 31 December 24240,000240,000
Net book value
At 31 December 24240,000240,000
At 31 December 23240,000240,000
4.Creditors: amounts due within one year

2024

2023

££
Amounts owed to related parties321,612311,256
Taxation and social security-1,846
Total321,612313,102
5.Related party transactions
During the year the Directors loaned the Company £308,718 (2023 : £305,779). This amount incurred interest at the end of each month, in line with the Bank of England base rate. This amount was also repayable upon demand.